Sumitomo Pharma Co (SMDPY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 18 38 sessions, February 4, 2026 to November 6, 2026
- Largest daily move
- +65.4% close of February 19, 2026
- 1-month change
- +17% closing prices, October 2, 2026 to November 6, 2026
Company Description
Sumitomo Pharma Co (OTC: SMDPY) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $5.4B.
SMDPY has gained 17.0% over the past month. The last closing price was $12.08.
This page collects what Stock Titan holds for SMDPY, including price data, latest news, and short interest trends.
Stock Performance
Sumitomo Pharma Co (SMDPY) closed at $12.08 on November 6, 2026. Over the past month, the price has gained 17.0%.
SMDPY Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Sumitomo Pharma Co has 1 recent news article. View all SMDPY news →
SEC Filings
Short Interest History
Short interest in Sumitomo Pharma Co (SMDPY) currently stands at 996 shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since February 2026, short interest has increased by 1264.4%.
Days to Cover History
Days to cover for Sumitomo Pharma Co (SMDPY) currently stands at 3.4 days, down 14.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 239%. Across the settlements charted above, it has ranged from 1.0 to 4.0 days.
SMDPY Company Profile & Sector Positioning
Sumitomo Pharma Co (SMDPY) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing SMDPY often look at related companies in the same sector, including Hikma Pharms PLC (HKMPY), Hikma Pharmaceuticals PLC (HKMPF), Kyowa Hakko Kogy (KYKOY), Almirall SA (ALMRY), and Hypera SA (HYPMY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SMDPY's relative position within its industry.